NasdaqCM - Nasdaq Real Time Price USD
Cognition Therapeutics, Inc. (CGTX)
0.2821
-0.0479
(-14.52%)
As of 11:36:54 AM EDT. Market Open.
Insider Roster
Insider roster data is derived solely from the last 24 months of Form 3 & Form 4 SEC filings.
| Individual or Entity | Most Recent Transaction | Date | Shares Owned as of Transaction Date |
|---|---|---|---|
| CAGGIANO ANTHONY Officer | Stock Award(Grant) | Feb 4, 2025 | 423,850 |
| DOYLE JOHN BRENDAN Chief Financial Officer | Stock Award(Grant) | Feb 4, 2025 | 416,125 |
| FLETCHER AARON G.L. Director and Beneficial Owner of more than 10% of a Class of Security | Stock Award(Grant) | Jun 7, 2024 | -- |
| KHATTAR JACK A Director | Stock Award(Grant) | Jun 7, 2024 | 14,500 |
| KREIS LESLIE W JR Director and Beneficial Owner of more than 10% of a Class of Security | Stock Award(Grant) | Nov 8, 2023 | -- |
| MONIA BRETT P Director | Stock Award(Grant) | Jun 7, 2024 | 14,500 |
| RICCIARDI LISA Chief Executive Officer | Stock Award(Grant) | Feb 4, 2025 | 932,536 |
| RICHSTONE ELLEN B Director | Stock Award(Grant) | Jun 7, 2024 | 24,500 |
| WALLACE PEGGY Director | Stock Award(Grant) | Jun 7, 2024 | 52,461 |
Related Tickers
ACTU Actuate Therapeutics, Inc. Common stock
10.35
+4.55%
INAB IN8bio, Inc.
0.1629
-2.98%
AVXL Anavex Life Sciences Corp.
8.45
-1.28%
ELEV Elevation Oncology, Inc.
0.3584
-0.61%
TNFA TNF Pharmaceuticals, Inc.
0.1878
-4.47%
QNRX Quoin Pharmaceuticals, Ltd.
6.20
-3.28%
ALZN Alzamend Neuro, Inc.
0.5306
-1.74%
RNTX Rein Therapeutics Inc.
1.8000
+3.45%
CRVS Corvus Pharmaceuticals, Inc.
4.2900
+28.06%
IRD Opus Genetics, Inc.
0.9804
-1.54%